Lessee, Operating Lease, Liability, to be Paid, Year Two of Vistagen Therapeutics, Inc. from 30 Jun 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Vistagen Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two in USD history and change rate from 30 Jun 2019 to 31 Mar 2025.
  • Vistagen Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Two for the quarter ending 31 Mar 2025 was $753,000, a 2.9% increase year-over-year.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Two, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Two, YoY Quarterly Change (%)

Vistagen Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Two (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $753,000 +$21,000 +2.9% 31 Mar 2025 10-K 17 Jun 2025 2025 FY
Q1 2024 $732,000 +$21,800 +3.1% 31 Mar 2024 10-K 11 Jun 2024 2024 FY
Q2 2023 $710,200 $0 0% 30 Jun 2023 10-Q 10 Aug 2023 2024 Q1
Q1 2023 $710,200 +$20,700 +3% 31 Mar 2023 10-K 28 Jun 2023 2023 FY
Q4 2022 $710,200 +$20,700 +3% 31 Dec 2022 10-Q 07 Feb 2023 2022 Q3
Q3 2022 $710,200 -$55,800 -7.3% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q2
Q2 2022 $710,200 -$15,800 -2.2% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q1
Q1 2022 $689,500 -$36,500 -5% 31 Mar 2022 10-K 23 Jun 2022 2022 FY
Q4 2021 $689,500 +$21,100 +3.2% 31 Dec 2021 10-Q 10 Feb 2022 2022 Q3
Q3 2021 $766,000 +$97,600 +15% 30 Sep 2021 10-Q 10 Nov 2021 2022 Q2
Q2 2021 $726,000 +$57,600 +8.6% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q1
Q1 2021 $726,000 +$57,600 +8.6% 31 Mar 2021 10-K 29 Jun 2021 2021 FY
Q4 2020 $668,400 +$22,600 +3.5% 31 Dec 2020 10-Q 11 Feb 2021 2021 Q3
Q3 2020 $668,400 +$22,600 +3.5% 30 Sep 2020 10-Q 12 Nov 2020 2021 Q2
Q2 2020 $668,400 +$22,600 +3.5% 30 Jun 2020 10-Q 13 Aug 2020 2021 Q1
Q1 2020 $668,400 31 Mar 2020 10-K 29 Jun 2020 2020 FY
Q4 2019 $645,800 31 Dec 2019 10-Q 13 Feb 2020 2020 Q3
Q3 2019 $645,800 30 Sep 2019 10-Q 07 Nov 2019 2020 Q2
Q2 2019 $645,800 30 Jun 2019 10-Q 13 Aug 2019 2020 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.